3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Condylomata Acuminata
1
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
human papillomavirus vaccine, L1 type 16, 18
1
Vaccines, Synthetic
1
Vaccines
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Hepatitis B Vaccines
1
Electrocoagulation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Condylomata Acuminata
×
Vaccines, Synthetic
×
1 year
×
Clear all
NCT00092534
2025-08-01
FUTURE II
Merck Sharp & Dohme LLC
Phase 3
Completed
12,167 enrolled
23 charts